Nationally recognized for excellence in endocrinology
The Division of Endocrinology, Diabetes and Metabolism has been recognized for excellence by U.S. News and World Report on an ongoing basis. We are committed to excellence in clinical care, the education of medical students, residents and fellows and to new discoveries to improve the care of patients with endocrine and endocrine-related disorders through laboratory and clinical research. Our division has a long history of outstanding performance in all of these areas and has recognized programs in diabetes, thyroid cancer and other thyroid disorders, adrenal and pituitary disorders and metabolic bone disease.Our board-certified endocrinologists provide clinical care for patients with all forms of endocrine diseases. Our experts in endocrinology accept referrals throughout the region as well as from around the country. Learn more about how Ohio State is leading the way in diabetes innovation.
Most recently, Matthew Ringel, MD, has been appointed Editor-in-Chief of Endocrine-Related Cancer and will officially take over on Jan. 1, 2021. Dr. Ringel’s research focuses on basic and translational thyroid cancer, including cell signaling, genetics and cancer metastasis. He hopes to build on the journal’s strong position in the community by strengthening links with the journal’s associated societies, and by using the journal as a vehicle to support the career development of early-career researchers.